02/18/2026 | Press release | Distributed by Public on 02/18/2026 07:36
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) Change in Officer Position
Effective March 16, 2026, Eric Olson will cease serving as President of SINTX Technologies, Inc. (the "Company") and will continue to serve as Chairman of the Board and Chief Executive Officer of the Company.
(c) Appointment of President
On February 17, 2026, the Company announced the appointment of Ryan Elmore as President of the Company, effective March 16, 2026. Mr. Elmore will report to the Company's Chief Executive Officer.
Mr. Elmore has over 20 years of leadership experience in the medical device and life sciences industries, including senior executive roles with responsibility for research and development, commercial operations, and international business expansion. Prior to joining the Company, Mr. Elmore served in various leadership positions at Invibio, a division of Victrex plc. He most recently served as Core Business Director since September 2021, where he was responsible for commercial leadership within advanced biomaterials and medical device markets. From October 2010 to November 2021, he served as Global Head of Sales, with responsibility for global commercial strategy and sales execution.
There are no arrangements or understandings between Mr. Elmore and any other person pursuant to which he was selected as President. There are no family relationships between Mr. Elmore and any director or executive officer of the Company, and there are no related party transactions involving Mr. Elmore that would require disclosure under Item 404(a) of Regulation S-K.
(c)(3) Executive Employment Agreement
In connection with his appointment, the Company entered into an Executive Employment Agreement with Mr. Elmore, effective February 6, 2026, with an employment commencement date of March 16, 2026.
Pursuant to the agreement:
| ● | Base Salary: $375,000 per year. | |
| ● | Annual Bonus: Eligible for an annual cash bonus with a target opportunity of 35% of base salary. Mr. Elmore's annual bonus for his first year of employment is guaranteed. | |
| ● | Sign-On Bonus: $100,000 payable upon commencement of employment, subject to repayment if Mr. Elmore voluntarily terminates employment within twelve months of his start date. | |
| ● | Equity Awards: Upon commencement of employment, Mr. Elmore will receive a restricted stock unit award with a grant date value of $300,000, with 20% vesting on the grant date and the remainder vesting in equal installments over the following 24 months, subject to continued employment. He will also be eligible to receive additional equity awards, including awards tied to the achievement of specified international business milestones. | |
| ● | Benefits: Eligible to participate in the Company's employee benefit plans available to senior executives. |